ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $217,000 | +38.2% | 11,750 | 0.0% | 0.05% | +28.9% |
| Q3 2021 | $157,000 | -27.6% | 11,750 | 0.0% | 0.04% | -26.9% |
| Q2 2021 | $217,000 | +23.3% | 11,750 | 0.0% | 0.05% | +15.6% |
| Q1 2021 | $176,000 | +3.5% | 11,750 | 0.0% | 0.04% | -2.2% |
| Q4 2020 | $170,000 | +77.1% | 11,750 | 0.0% | 0.05% | +64.3% |
| Q3 2020 | $96,000 | +20.0% | 11,750 | 0.0% | 0.03% | +12.0% |
| Q2 2020 | $80,000 | -3.6% | 11,750 | 0.0% | 0.02% | -16.7% |
| Q1 2020 | $83,000 | -27.8% | 11,750 | 0.0% | 0.03% | -14.3% |
| Q4 2019 | $115,000 | -10.9% | 11,750 | 0.0% | 0.04% | -18.6% |
| Q3 2019 | $129,000 | -5.8% | 11,750 | 0.0% | 0.04% | -4.4% |
| Q2 2019 | $137,000 | +22.3% | 11,750 | 0.0% | 0.04% | +18.4% |
| Q1 2019 | $112,000 | -0.9% | 11,750 | 0.0% | 0.04% | -9.5% |
| Q4 2018 | $113,000 | -32.3% | 11,750 | 0.0% | 0.04% | -25.0% |
| Q3 2018 | $167,000 | +9.2% | 11,750 | -7.8% | 0.06% | +3.7% |
| Q2 2018 | $153,000 | -2.5% | 12,750 | 0.0% | 0.05% | -3.6% |
| Q1 2018 | $157,000 | -16.9% | 12,750 | -1.9% | 0.06% | -17.6% |
| Q4 2017 | $189,000 | -1.0% | 13,000 | -3.0% | 0.07% | -6.8% |
| Q3 2017 | $191,000 | +5.5% | 13,400 | -5.6% | 0.07% | 0.0% |
| Q2 2017 | $181,000 | +0.6% | 14,200 | 0.0% | 0.07% | -1.4% |
| Q1 2017 | $180,000 | +24.1% | 14,200 | 0.0% | 0.07% | +15.6% |
| Q4 2016 | $145,000 | -23.3% | 14,200 | -0.9% | 0.06% | -23.8% |
| Q3 2016 | $189,000 | +3.8% | 14,325 | 0.0% | 0.08% | +1.2% |
| Q2 2016 | $182,000 | -5.7% | 14,325 | -2.1% | 0.08% | -7.8% |
| Q1 2016 | $193,000 | -14.2% | 14,625 | 0.0% | 0.09% | -29.7% |
| Q4 2015 | $225,000 | +24.3% | 14,625 | 0.0% | 0.13% | +19.6% |
| Q3 2015 | $181,000 | -7.7% | 14,625 | +2.1% | 0.11% | -2.7% |
| Q2 2015 | $196,000 | +14.6% | 14,325 | 0.0% | 0.11% | +11.1% |
| Q1 2015 | $171,000 | -6.6% | 14,325 | 0.0% | 0.10% | -11.6% |
| Q4 2014 | $183,000 | – | 14,325 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |